Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sanara MedTech Inc.SMTI · Entity 5880 | Director · Principal Executive Officer | December 22, 2021 | December 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sanara MedTech Inc.
Report date December 22, 2021 · Filed December 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,113 |
Reported balance
After 2021-12-22 transaction · row 1
1 source rowRow 1 · 2021-12-22 · Grant · Acquired 3,549 · Balance 22,113 F1: Represents restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Long-Term Incentive Plan, as amended and restated. The shares will vest on January 3, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Long-Term Incentive Plan, as amended and restated. The shares will vest on January 3, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2021 Filed Dec 23, 2021 21:30 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 3,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-032400 · ownership.xml · nonDerivative · entry 1 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,113 F1 · shares: Represents restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Long-Term Incentive Plan, as amended and restated. The shares will vest on January 3, 2022. Read SEC document |
| December 16, 2021 Filed Dec 21, 2021 00:24 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 174 | $35.53 | $6,182.22 |
DisclosureSEC source: 0001493152-21-032091 · ownership.xml · nonDerivative · entry 4 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,564 F3 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 712 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F3 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 712 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 16, 2021 Filed Dec 21, 2021 00:24 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 174 | $45.67 | $7,946.58 |
DisclosureSEC source: 0001493152-21-032091 · ownership.xml · nonDerivative · entry 3 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,738 F2 · shares: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 713 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F2 · price: Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 713 shares of restricted stock granted to the reporting person on September 30, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 16, 2021 Filed Dec 21, 2021 00:24 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | Tax withholdingCommon Stock | 1,400 | $45.67 | $63,938.00 |
DisclosureSEC source: 0001493152-21-032091 · ownership.xml · nonDerivative · entry 2 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,912 F1 · shares: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,749 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. F1 · price: Represents shares of common stock of Sanara MedTech, Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 5,749 shares of restricted stock granted to the reporting person on February 24, 2020. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market. Read SEC document |
| December 31, 2020 Filed Dec 21, 2021 00:24 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 546 | $10.53 | $5,749.38 |
DisclosureSEC source: 0001493152-21-032091 · ownership.xml · nonDerivative · entry 1 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,312 Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 22:49 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,092 | $10.53 | $11,498.76 |
DisclosureSEC source: 0000897423-20-000098 · edgar.xml · nonDerivative · entry 2 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,766 Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 22:49 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 1,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000098 · edgar.xml · nonDerivative · entry 1 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,674 Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 16:04 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 12,049 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000053 · edgar.xml · nonDerivative · entry 2 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,249 Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 16:04 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 5,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000053 · edgar.xml · nonDerivative · entry 1 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Read SEC document |
| February 10, 2020 Filed Feb 10, 2020 23:49 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | OtherCommon Stock | 12,049 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000027 · edgar.xml · nonDerivative · entry 2 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 12,049 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. F2 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 12,049 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. Read SEC document |
| February 10, 2020 Filed Feb 10, 2020 23:49 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | OtherCommon Stock | 5,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000897423-20-000027 · edgar.xml · nonDerivative · entry 1 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,049 F1 · kind: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 5,200 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. F1 · price: On January 7, 2020 the Issuer's Board of Directors approved the grant to the Reporting Person of 5,200 shares of restricted stock to be effective January 21, 2020, subject to specified conditions, but prior to the completion of the grant and the issuance of such shares, the Issuer's Board of Directors, on February 10, 2020, rescinded the grant of all such shares of the restricted stock. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:50 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 12,049 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000018 · edgar.xml · nonDerivative · entry 2 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,249 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 21:50 UTC | Sanara MedTech Inc. SMTI · Entity 5880 | GrantCommon Stock | 5,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000897423-20-000018 · edgar.xml · nonDerivative · entry 1 Carmena J Michael · CIK 0001732645 · Director · Principal Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.